株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

放射線治療の世界市場:種類別(外部照射治療、内部照射治療/小線源治療 、全身照射治療)、エンドユーザー別:世界の機会分析と産業予測

Radiotherapy Market by Type, and End User - Global Opportunity Analysis and Industry Forecast, 2017-2023

発行 Allied Market Research 商品コード 529385
出版日 ページ情報 英文 140 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=107.15円で換算しております。
Back to Top
放射線治療の世界市場:種類別(外部照射治療、内部照射治療/小線源治療 、全身照射治療)、エンドユーザー別:世界の機会分析と産業予測 Radiotherapy Market by Type, and End User - Global Opportunity Analysis and Industry Forecast, 2017-2023
出版日: 2017年06月01日 ページ情報: 英文 140 Pages
概要

当レポートでは、世界の放射線治療市場について調査分析を行い、市場概要、種類別、エンドユーザー別、地域別の考察、主要企業のプロファイルなどについてまとめています。

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場概要

  • 市場の定義と範囲
  • 主な調査結果
  • 市場シェア分析
  • 市場のダイナミクス
    • 促進因子
    • 抑制因子
    • 機会
    • 影響分析
  • 臨床試験

第4章 放射線治療市場:種類別

  • 概要
  • 外部照射治療
  • 内部照射治療/小線源治療
  • 全身照射治療

第5章 放射線治療市場:エンドユーザー別

  • 概要
  • 病院/外来診療所
  • 外来外科センター(ASCS)

第6章 放射線治療市場:地域別

  • 概要
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ/中東/アフリカ

第7章 企業プロファイル

図表

List of Tables

  • TABLE 1. GLOBAL RADIOTHERAPY MARKET, BY TYPE, 2016-2023 ($MILLION)
  • TABLE 2. GLOBAL EXTERNAL BEAM RADIATION THERAPY MARKET, BY REGION, 2016-2023 ($MILLION)
  • TABLE 3. GLOBAL EXTERNAL BEAM RADIATION THERAPY MARKET, BY PRODUCT, 2016-2023 ($MILLION)
  • TABLE 4. GLOBAL COMPACT ADVANCED RADIOTHERAPY SYSTEMS MARKET, BY PRODUCT, 2016-2023 ($MILLION)
  • TABLE 5. GLOBAL EXTERNAL BEAM RADIATION THERAPY MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
  • TABLE 6. GLOBAL EXTERNAL BEAM RADIATION THERAPY MARKET, BY APPLICATION, 2016-2023 ($MILLION)
  • TABLE 7. GLOBAL INTERNAL RADIATION THERAPY/BRACHYTHERAPY MARKET, BY REGION, 2016-2023 ($MILLION)
  • TABLE 8. GLOBAL INTERNAL RADIATION THERAPY MARKET, BY PRODUCT, 2016-2023 ($MILLION)
  • TABLE 9. GLOBAL INTERNAL RADIATION THERAPY MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
  • TABLE 10. GLOBAL INTERNAL RADIATION THERAPY MARKET, BY APPLICATION, 2016-2023 ($MILLION)
  • TABLE 11. GLOBAL SYSTEMIC RADIATION THERAPY MARKET, BY REGION, 2016-2023 ($MILLION)
  • TABLE 12. GLOBAL RADIOTHERAPY MARKET, BY END USER, 2016-2023 ($MILLION)
  • TABLE 13. RADIOTHERAPY MARKET FOR HOSPITALS & CLINICS, BY REGION, 2016-2023 ($MILLION)
  • TABLE 14. RADIOTHERAPY MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2016-2023 ($MILLION)
  • TABLE 15. RADIOTHERAPY MARKET, BY REGION, 2016-2023 ($MILLION)
  • TABLE 16. CANCER INCIDENCE IN NORTH AMERICA (U.S., CANADA, AND MEXICO)
  • TABLE 17. NORTH AMERICA RADIOTHERAPY MARKET, BY COUNTRY ($MILLION), 2016-2023
  • TABLE 18. NORTH AMERICA RADIOTHERAPY MARKET, BY PRODUCT, 2016-2023 ($MILLION)
  • TABLE 19. NORTH AMERICA RADIOTHERAPY MARKET, BY END USER, 2016-2023 ($MILLION)
  • TABLE 20. CANCER INCIDENCE IN EUROPEAN UNION (EU-28)
  • TABLE 21. EUROPE RADIOTHERAPY MARKET, BY COUNTRY ($MILLION), 2016-2023
  • TABLE 22. EUROPE RADIOTHERAPY MARKET, BY PRODUCT, 2016-2023 ($MILLION)
  • TABLE 23. EUROPE RADIOTHERAPY MARKET, BY END USER ($MILLION), 2016-2023
  • TABLE 24. CANCER INCIDENCE IN ASIA
  • TABLE 25. ASIA-PACIFIC RADIOTHERAPY MARKET, BY COUNTRY ($MILLION), 2016-2023
  • TABLE 26. ASIA-PACIFIC RADIOTHERAPY MARKET, BY PRODUCT, 2016-2023 ($MILLION)
  • TABLE 27. ASIA-PACIFIC RADIOTHERAPY MARKET, BY END USER ($MILLION), 2016-2023
  • TABLE 28. CANCER INCIDENCE IN AFRICA
  • TABLE 29. LAMEA RADIOTHERAPY MARKET, BY COUNTRY ($MILLION), 2016-2023
  • TABLE 30. LAMEA RADIOTHERAPY MARKET, BY PRODUCT, 2016-2023 ($MILLION)
  • TABLE 31. LAMEA RADIOTHERAPY MARKET, BY END USER ($MILLION), 2016-2023
  • TABLE 37. ACCURAY: COMPANY SNAPSHOT
  • TABLE 38. ACCURAY: OPERATING SEGMENTS
  • TABLE 39. C. R. BARD: COMPANY SNAPSHOT
  • TABLE 40. C. R. BARD: OPERATING SEGMENTS
  • TABLE 41. ELEKTA: COMPANY SNAPSHOT
  • TABLE 42. ELEKTA: OPERATING SEGMENTS
  • TABLE 43. IBA: COMPANY SNAPSHOT
  • TABLE 44. IBA: OPERATING SEGMENTS
  • TABLE 45. ISORAY MEDICAL: COMPANY SNAPSHOT
  • TABLE 46. ISORAY MEDICAL: OPERATING SEGMENTS
  • TABLE 47. MEVION: COMPANY SNAPSHOT
  • TABLE 48. MEVION: OPERATING SEGMENTS
  • TABLE 49. MITSUBISHI ELECTRIC: COMPANY SNAPSHOT
  • TABLE 50. MITSUBISHI ELECTRIC: OPERATING SEGMENTS
  • TABLE 51. NORDION: COMPANY SNAPSHOT
  • TABLE 52. NORDION: OPERATING SEGMENTS
  • TABLE 53. RAYSEARCH LABORATORIES: COMPANY SNAPSHOT
  • TABLE 54. RAYSEARCH LABORATORIES: OPERATING SEGMENTS
  • TABLE 55. VARIAN MEDICAL: COMPANY SNAPSHOT
  • TABLE 56. VARIAN MEDICAL: OPERATING SEGMENTS

List of Figures

  • FIGURE 1. RADIOTHERAPY MARKET SEGMENTATION
  • FIGURE 2. TOP INVESTMENT POCKETS
  • FIGURE 3. TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION, (2014-2016)
  • FIGURE 4. TOP WINNING STRATEGIES: NATURE AND TYPE
  • FIGURE 5. TOP COMPANIES AND THEIR STRATEGIES
  • FIGURE 6. DETAILED STRUCTURE OF COMPANIES AND NATURE OF STRATEGIES
  • FIGURE 7. DETAILED STRUCTURE OF COMPANIES AND TYPE OF STRATEGIES
  • FIGURE 8. MARKET SHARE ANALYSIS, RADIOTHERAPY MARKET, 2016
  • FIGURE 9. IMPACT ANALYSIS: RADIOTHERAPY MARKET
  • FIGURE 10. GEOGRAPHICAL DISTRIBUTION OF COMPLETED CLINICAL TRIALS IN RADIOTHERAPY MARKET (%)
  • FIGURE 11. GLOBAL SYSTEMIC RADIATION THERAPY MARKET, 2016-2023 ($MILLION)
  • FIGURE 12. U.S. RADIOTHERAPY MARKET ($MILLION), 2016-2023
  • FIGURE 13. CANADA RADIOTHERAPY MARKET ($MILLION), 2016-2023
  • FIGURE 14. MEXICO RADIOTHERAPY MARKET ($MILLION), 2016-2023
  • FIGURE 15. DISTRIBUTION OF THE EUROPEAN UNION (EU) POPULATION AGED 18 OR OVER BY BODY MASS INDEX, 2014 (%)
  • FIGURE 16. GERMANY RADIOTHERAPY MARKET ($MILLION), 2016-2023
  • FIGURE 17. FRANCE RADIOTHERAPY MARKET ($MILLION), 2016-2023
  • FIGURE 18. UK RADIOTHERAPY MARKET ($MILLION), 2016-2023
  • FIGURE 19. ITALY RADIOTHERAPY MARKET ($MILLION), 2016-2023
  • FIGURE 20. SPAIN RADIOTHERAPY MARKET ($MILLION), 2016-2023
  • FIGURE 21. REST OF EUROPE RADIOTHERAPY MARKET ($MILLION), 2016-2023
  • FIGURE 22. JAPAN RADIOTHERAPY MARKET ($MILLION), 2016-2023
  • FIGURE 23. CHINA RADIOTHERAPY MARKET ($MILLION), 2016-2023
  • FIGURE 24. INDIA RADIOTHERAPY MARKET ($MILLION), 2016-2023
  • FIGURE 25. SOUTH KOREA RADIOTHERAPY MARKET ($MILLION), 2016-2023
  • FIGURE 26. AUSTRALIA RADIOTHERAPY MARKET ($MILLION), 2016-2023
  • FIGURE 27. REST OF ASIA-PACIFIC RADIOTHERAPY MARKET ($MILLION), 2016-2023
  • FIGURE 28. BRAZIL RADIOTHERAPY MARKET ($MILLION), 2016-2023
  • FIGURE 29. SOUTH AFRICA RADIOTHERAPY MARKET ($MILLION), 2016-2023
  • FIGURE 30. SAUDI ARABIA RADIOTHERAPY MARKET ($MILLION), 2016-2023
  • FIGURE 31. REST OF LAMEA RADIOTHERAPY MARKET ($MILLION), 2016-2023
目次
Product Code: LI 172367

Radiotherapy is also known as radiation therapy, which utilizes high-energy radiation to kill cancer cells and reduce tumors. It involves the use of various rays including X-rays, gamma rays, and charged particles. During radiotherapy, radiation can be delivered to the body tissues internally as well as externally. According to the National Cancer Institute, around half of all the cancer patient population receives some type of radiation therapy during their treatment.

The global radiotherapy market was valued at $4,723 million in 2016, and is expected to reach at $7,222 million by 2023, growing at a CAGR of 6.2% from 2017 to 2023. The market is driven by growth in number of cancer patients, increase in geriatric population, rise in adoption of radiotherapy devices and procedures, owing to surge in number of awareness campaigns about the benefits of radiotherapy, and technological advancements in radiotherapy devices. However, lack of skilled personnel and difficulty in tumor visualization restrict the market growth. Conversely, growth opportunities in emerging markets and rise in demand for cancer treatment are expected to provide several opportunities for market growth during the forecast period.

The report segments the market based on type, end user, and region. Based on type, it is divided into external beam radiation therapy, internal radiation therapy/brachytherapy, and systemic radiation therapy. Based on end user, it is categorized into hospitals & clinics and ambulatory surgical centers. Based on region, it is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, Italy, UK, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Colombia, Saudi Arabia, and rest of LAMEA).

KEY BENEFITS FOR STAKEHOLDERS

  • The study provides an in-depth analysis of the market with current trends and future estimations to elucidate the imminent investment pockets.
  • It offers a quantitative analysis and comprehensive analysis of all geographical regions from 2016 to 2023 to enable the stakeholders to capitalize on the prevailing market opportunities.
  • Extensive analysis by type helps to understand the various types of devices used for radiotherapy.
  • Key players are profiled and their strategies are analyzed thoroughly to understand competitive outlook of the global market.

KEY MARKET SEGMENTS

BY TYPE

  • External Beam Radiation Therapy
  • By Product
  • Compact Advanced Radiotherapy Systems
  • Cyberknife
  • Gamma Knife
  • Tomotherapy
  • Proton Therapy Systems
  • Conventional Radiotherapy Systems

By Technology

  • Image-Guided Radiotherapy (IGRT)
  • Intensity Modulated Radiotherapy (IMRT)
  • Stereotactic Technology
  • Proton Beam Therapy
  • 3D Conformal Radiotherapy (3D CRT)
  • Volumetric Modulated Arc Therapy (VMAT)

By Application

  • Prostate Cancer
  • Breast Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Other
  • Internal Radiation Therapy/Brachytherapy

By Product

  • Seeds & Applicators
  • Electronic Brachytherapy

By Technology

  • Low Dose Rate
  • High Dose Rate

By Application

  • Prostate Cancer
  • Gynecological Cancer
  • Breast Cancer
  • Other
  • Systemic Radiation Therapy

BY END USER

  • Hospitals & Clinics
  • Ambulatory Surgical Centers

BY REGION

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • South Africa
  • Saudi Arabia
  • Rest of LAMEA
  • LIST OF KEY PLAYERS PROFILED IN THE REPORT
  • Varian Medical Systems, Inc.
  • Elekta AB
  • Accuray Incorporated
  • IBA (Ion Beam Applications Sa)
  • Nordion, Inc.
  • C. R. Bard, Inc.
  • Isoray Medical, Inc.
  • Raysearch Laboratories AB
  • Mevion Medical Systems, Inc.
  • Mitsubishi Electric Corporation
  • LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request)
  • Shenzhen GeneMDx Biotech. Co., Ltd.
  • Vision RT Ltd.
  • IntraOp Medical, Inc.
  • Eckert & Ziegler
  • Theragenics Corporation

Table of Contents

CHAPTER 1 INTRODUCTION

  • 1.1. REPORT DESCRIPTION
  • 1.2. KEY BENEFITS FOR STAKEHOLDERS
  • 1.3. KEY MARKET SEGMENTS
  • 1.4. RESEARCH METHODOLOGY
    • 1.4.1. Secondary research
    • 1.4.2. Primary research
    • 1.4.3. Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY

  • 2.1. KEY FINDINGS OF THE STUDY
  • 2.2. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

  • 3.1. MARKET DEFINITION AND SCOPE
  • 3.2. KEY FINDINGS
    • 3.2.1. Top investment pockets
    • 3.2.2. Top winning strategies
      • 3.2.2.1. Competitive intelligence of companies and their strategies
  • 3.3. MARKET SHARE ANALYSIS, 2016
  • 3.4. MARKET DYNAMICS
    • 3.4.1. Drivers
      • 3.4.1.1. Growing number of cancer patients
      • 3.4.1.2. Increasing ageing population
      • 3.4.1.3. Rising awareness and increasing adoption of radiotherapy devices and procedures
      • 3.4.1.4. Technological advancements in radiotherapy devices
    • 3.4.2. Restraints
      • 3.4.2.1. Dearth of skilled personnel
      • 3.4.2.2. Difficulty in tumor visualization
    • 3.4.3. Opportunities
      • 3.4.3.1. Growth opportunities in emerging markets
      • 3.4.3.2. Increasing demand for cancer treatment
    • 3.4.4. Impact analysis
  • 3.5. CLINICAL TRIALS

CHAPTER 4 GLOBAL RADIOTHERAPY MARKET, BY TYPE

  • 4.1. OVERVIEW
    • 4.1.1. Market size and forecast
  • 4.2. EXTERNAL BEAM RADIATION THERAPY
    • 4.2.1. Key market trends
    • 4.2.2. Key growth factors and opportunities
    • 4.2.3. Market size and forecast
    • 4.2.4. External beam radiation therapy market, by product
    • 4.2.5. Market size and forecast
      • 4.2.5.1. Compact advanced radiotherapy systems
      • 4.2.5.1.1. Market size and forecast
      • 4.2.5.1.2. CyberKnife
      • 4.2.5.1.2.1. Market size and forecast
      • 4.2.5.1.3. Gamma Knife
      • 4.2.5.1.3.1. Market size and forecast
      • 4.2.5.1.4. Tomotherapy
      • 4.2.5.1.4.1. Market size and forecast
      • 4.2.5.2. Proton therapy systems
      • 4.2.5.2.1. Market size and forecast
      • 4.2.5.3. Conventional radiotherapy systems
      • 4.2.5.3.1. Market size and forecast
    • 4.2.6. External beam radiation therapy, by technology
    • 4.2.7. Market size and forecast
      • 4.2.7.1. 3D Conformal Radiotherapy (3D CRT)
      • 4.2.7.1.1. Market size & forecast
      • 4.2.7.2. Image-Guided Radiotherapy (IGRT)
      • 4.2.7.2.1. Market size & forecast
      • 4.2.7.3. Intensity Modulated Radiotherapy (IMRT)
      • 4.2.7.3.1. Market size & forecast
      • 4.2.7.4. Stereotactic Technology
      • 4.2.7.4.1. Market size & forecast
      • 4.2.7.5. Proton Beam Therapy
      • 4.2.7.5.1. Market size & forecast
      • 4.2.7.6. Volumetric Modulated Arc Therapy (VMAT)
      • 4.2.7.6.1. Market size & forecast
    • 4.2.8. External beam radiation therapy, by application
    • 4.2.9. Market size & forecast
      • 4.2.9.1. Prostate Cancer
      • 4.2.9.1.1. Market size & forecast
      • 4.2.9.2. Breast Cancer
      • 4.2.9.2.1. Market size & forecast
      • 4.2.9.3. Lung Cancer
      • 4.2.9.3.1. Market size & forecast
      • 4.2.9.4. Colorectal Cancer
      • 4.2.9.4.1. Market size & forecast
      • 4.2.9.5. Other
      • 4.2.9.5.1. Market size & forecast
  • 4.3. INTERNAL RADIATION THERAPY/BRACHYTHERAPY
    • 4.3.1. Key market trends
    • 4.3.2. Key growth factors and opportunities
    • 4.3.3. Market size and forecast
    • 4.3.4. Brachytherapy market, by product
    • 4.3.5. Market size and forecast
      • 4.3.5.1. Implants & applicators
      • 4.3.5.1.1. Market size and forecast
      • 4.3.5.2. Electronic brachytherapy devices
      • 4.3.5.2.1. Market size and forecast
    • 4.3.6. Brachytherapy market, by technology
    • 4.3.7. Market size and forecast
      • 4.3.7.1. Low dose rate
      • 4.3.7.1.1. Market size and forecast
      • 4.3.7.2. High dose rate
      • 4.3.7.2.1. Market size and forecast
    • 4.3.8. Brachytherapy market, by application
    • 4.3.9. Market size and forecast
      • 4.3.9.1. Prostate cancer
      • 4.3.9.1.1. Market size and forecast
      • 4.3.9.2. Gynecological cancer
      • 4.3.9.2.1. Market size and forecast
      • 4.3.9.3. Breast cancer
      • 4.3.9.3.1. Market size and forecast
      • 4.3.9.4. Other
      • 4.3.9.4.1. Market size and forecast
  • 4.4. SYSTEMIC RADIATION THERAPY
    • 4.4.1. Key market trends
    • 4.4.2. Key growth factors and opportunities
    • 4.4.3. Market size and forecast

CHAPTER 5 RADIOTHERAPY MARKET, BY END USER

  • 5.1. OVERVIEW
    • 5.1.1. Market size and forecast
  • 5.2. HOSPITALS & CLINICS
    • 5.2.1. Market size and forecast
  • 5.3. AMBULATORY SURGICAL CENTERS (ASCS)
    • 5.3.1. Market size and forecast

CHAPTER 6 RADIOTHERAPY MARKET, BY REGION

  • 6.1. OVERVIEW
    • 6.1.1. Market size and forecast
  • 6.2. NORTH AMERICA
    • 6.2.1. Key market trends
    • 6.2.2. Key growth factors and opportunities
    • 6.2.3. Market size and forecast
    • 6.2.4. U.S.
    • 6.2.5. Canada
    • 6.2.6. Mexico
  • 6.3. EUROPE
    • 6.3.1. Key market trends
    • 6.3.2. Key growth factors and opportunities
    • 6.3.3. Market size and forecast
    • 6.3.4. Germany
    • 6.3.5. France
    • 6.3.6. UK
    • 6.3.7. Italy
    • 6.3.8. Spain
    • 6.3.9. Rest of Europe
  • 6.4. ASIA-PACIFIC
    • 6.4.1. Key market trends
    • 6.4.2. Key growth factors and opportunities
    • 6.4.3. Market size and forecast
    • 6.4.4. Japan
    • 6.4.5. China
    • 6.4.6. India
    • 6.4.7. South Korea
    • 6.4.8. Australia
    • 6.4.9. Rest of Asia-Pacific
  • 6.5. LAMEA
    • 6.5.1. Key market trends
    • 6.5.2. Key growth factors and opportunities
    • 6.5.3. Market size and forecast
    • 6.5.4. Brazil
    • 6.5.5. South Africa
    • 6.5.6. Saudi Arabia
    • 6.5.7. Rest of LAMEA

CHAPTER 7 COMPANY PROFILES

  • 7.1. ACCURAY INCORPORATED
    • 7.1.1. Company overview
    • 7.1.2. Company snapshot
    • 7.1.3. Operating business segments
    • 7.1.4. Product portfolio
    • 7.1.5. Business performance
    • 7.1.7. Key strategic moves and developments
  • 7.2. C. R. BARD, INC.
    • 7.2.1. Company overview
    • 7.2.2. Company snapshot
    • 7.2.3. Operating business segments
    • 7.2.4. Product portfolio
    • 7.2.5. Key strategic moves and developments
  • 7.3. ELEKTA AB
    • 7.3.1. Company overview
    • 7.3.2. Company Snapshot
    • 7.3.3. Operating business segments
    • 7.3.4. Product portfolio
    • 7.3.5. Business performance
    • 7.3.7. Key strategic moves and developments
  • 7.4. IBA (ION BEAM APPLICATIONS SA)
    • 7.4.1. Company overview
    • 7.4.2. Company snapshot
    • 7.4.3. Operating business segments
    • 7.4.4. Key strategic moves and developments
  • 7.5. ISORAY MEDICAL, INC.
    • 7.5.1. Company overview
    • 7.5.2. Company snapshot
    • 7.5.3. Operating business segments
    • 7.5.4. Product portfolio
    • 7.5.5. Business performance
    • 7.5.7. Key strategic moves and developments
  • 7.6. MEVION MEDICAL SYSTEMS, INC.
    • 7.6.1. Company overview
    • 7.6.2. Company snapshot
    • 7.6.3. Operating business segments
    • 7.6.4. Product portfolio
    • 7.6.5. Business performance
    • 7.6.7. Key strategic moves and developments
  • 7.7. MITSUBISHI ELECTRIC CORPORATION
    • 7.7.1. Company overview
    • 7.7.2. Company snapshot
    • 7.7.3. Operating business segments
    • 7.7.4. Product portfolio
    • 7.7.5. Key strategic moves and developments
  • 7.8. NORDION, INC.
    • 7.8.1. Company overview
    • 7.8.2. Company snapshot
    • 7.8.3. Operating business segments
    • 7.8.4. Product portfolio
    • 7.8.5. Key strategic moves and developments
  • 7.9. RAYSEARCH LABORATORIES AB
    • 7.9.1. Company overview
    • 7.9.2. Company snapshot
    • 7.9.3. Operating product categories
    • 7.9.4. Product portfolio
    • 7.9.5. Business performance
    • 7.9.6. Key strategic moves and developments
  • 7.10. VARIAN MEDICAL SYSTEMS, INC.
    • 7.10.1. Company overview
    • 7.10.2. Company snapshot
    • 7.10.3. Operating business segments
    • 7.10.4. Product portfolio
Back to Top